For millions of people living with HIV, a daily regimen of medications is a lifelong necessity. If they stop taking the drugs—commonly referred to as antiretroviral therapy—the virus usually rushes ...
In patients with HIV‑1 infection and virologic suppression, switching to an investigational regimen of doravirine plus ...
A new study published in The Lancet Microbe reports the first twice-yearly injectable HIV treatment regimen—combining lenacapavir, teropavimab, and zinlirvimab—has achieved high rates of viral ...
Three experimental injectable antiretrovirals – a novel capsid inhibitor and two next-generation integrase inhibitors – could ...
Same-day ART initiation for patients with HIV infection and tuberculosis symptoms is as effective as deferring therapy until ...
A groundbreaking discovery reveals how HIV integrates its genetic material into human DNA, exposing a key viral vulnerability that could lead to new therapies and bring the world closer to a ...
Modern HIV treatment is one of medicine's great success stories. With today's therapies, many people living with HIV can ...
A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in the lab.
The shift could cut off tens of thousands of people from treatment.
Harerimana Ismail of Uganda is a community health worker who checks on kids with HIV. He lost his salary after the Trump ...
What are the three types of HIV tests available to patients, how do they differ, and how can patients determine the best option for them?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results